Search - tctmd.com

Displaying 1 - 20 of 25

Sort: Relevancy | Date

Presentation TCT 2016

Hybrid Surgical Approaches Offer the Best Options for Complex PAD: Case Examples

Presenter: Jihad A. Mustapha, Craig M. Walker, Koen Deloose

November 01, 2016

Presentation TCT 2016

Safety and Performance of the Shockwave Medical Lithoplasty System in Treating Calcified Peripheral Vascular Lesions: 6-Month Results from the Two-Phase DISRUPT PAD Study

Presenter: Michael D. Dake, Kenneth Rosenfield, Todd J. Brinton

November 01, 2016

Presentation TCT 2016

Results of the FIH Chocolate Touch Drug Coated Balloon Catheter for PAD: The ENDURE Trial

Presenter: Michael D. Dake, Kenneth Rosenfield, Mehdi H. Shishehbor

November 01, 2016

Presentation TCT 2016

Transcatheter Leaflet Extender for Mitral Valve Repair (MitraPlug)

Presenter: Ted Feldman, Juan F. Granada, Muralidhar Padala

October 30, 2016

News Conference News TCT 2015

VISION: OCT-Guided Atherectomy Safe, Effective for PAD Intervention

October 14, 2015

Presentation TCT 2015

Two US PAD Trials That May Well Change Your Practice: Updates on the ENDOMAX and LIBERTY-360 Studies

Presenter: Hans Krankenberg, Lindsay S. Machan, Herbert D. Aronow

October 11, 2015

Presentation TCT 2015

Update on Bioresorbable Scaffolds for PAD

Presenter: Prakash Krishnan, Mahmood K. Razavi

October 11, 2015

Presentation TCT 2015

PAR-1 Antagonists and P2Y12 Inhibitors: What Are the Data and the Place of These Medications in the PAD Population (for Secondary Cardiovascular Prevention and PAD Itself)?

Presenter: Gary M. Ansel, Michael R. Jaff, Ori Ben-Yehuda

October 11, 2015

Presentation TCT 2014

Side Cell Population and Valve Function

Presenter: Marc S. Penn, Andreas M. Zeiher, Warren Sherman, Muralidhar Padala

September 15, 2014

Presentation TCT 2014

Featured Presentation: Vorapaxar Safety and Efficacy Results in the FDA-Approved, Stroke-Free MI and PAD Populations

Presenter: Ori Ben-Yehuda, Matthew T. Roe, David J. Moliterno, Marc Bonaca

September 15, 2014

News Conference News TCT 2013

Pulmonary Artery Denervation Procedure May Improve Hemodynamic Outcomes in PAH

November 05, 2013

Presentation TCT 2013

How to Identify Elevated Genetic Risk for Failed AF Ablation (4q25)

Presenter: Paddy Barrett

October 31, 2013

Presentation TCT 2013

Optimized Medical Therapy for the PAD Patient, With or Without Intervention

Presenter: Michael Jaff

October 30, 2013

News Conference News TCT 2013

LEVANT 2, RIBS Show Promise for Paclitaxel-Coated Balloons in PAD and CAD

October 30, 2013

Presentation TCT 2013

Pulmonary artery denervation to treat pulmonary arterial hypertension: a single-center, prospective, first-in-man PADN-1 study

Presenter: Shao-?Liang Chen

October 29, 2013

Presentation TCT 2013

Pulmonary Artery Denervation for Pulmonary Hypertension: PADN-1 Results and Fuure Clinical Studies

Presenter: Shao Liang Chen

October 28, 2013

Presentation TCT 2013

Is There Utility in Close Duplex Follow-up After PAD Intervention?

Presenter: Khusrow Niazi

October 27, 2013

Presentation TCT 2013

Current Status of Lipid Lowering Therapy in CAD, PAD, and CKD

Presenter: Rita Redberg

October 27, 2013

Presentation TCT 2013

Per-Lesion Inter-observer Variability and Impact on Syntax Score

Presenter: Gerardo Nau, Pablo Lamelas, Mariano Albertal, Jorge Belardi, Lucio Padilla, Sebastian Peralta, Fabricio Torrent, Fernando Cura

January 31, 2013

Presentation TCT 2012

4q25 and Prediction of Atrial Fibrillation: How Can This Information Help the Clinician?

Presenter: Paddy Barrett

October 25, 2012

Advertisement

Hybrid Surgical Approaches Offer the Best Options for Complex PAD: Case Examples

Safety and Performance of the Shockwave Medical Lithoplasty System in Treating Calcified Peripheral Vascular Lesions: 6-Month Results from the Two-Phase DISRUPT PAD Study

Results of the FIH Chocolate Touch Drug Coated Balloon Catheter for PAD: The ENDURE Trial

Transcatheter Leaflet Extender for Mitral Valve Repair (MitraPlug)

VISION: OCT-Guided Atherectomy Safe, Effective for PAD Intervention

Two US PAD Trials That May Well Change Your Practice: Updates on the ENDOMAX and LIBERTY-360 Studies

Update on Bioresorbable Scaffolds for PAD

PAR-1 Antagonists and P2Y12 Inhibitors: What Are the Data and the Place of These Medications in the PAD Population (for Secondary Cardiovascular Prevention and PAD Itself)?

Side Cell Population and Valve Function

Featured Presentation: Vorapaxar Safety and Efficacy Results in the FDA-Approved, Stroke-Free MI and PAD Populations

Pulmonary Artery Denervation Procedure May Improve Hemodynamic Outcomes in PAH

How to Identify Elevated Genetic Risk for Failed AF Ablation (4q25)

Optimized Medical Therapy for the PAD Patient, With or Without Intervention

LEVANT 2, RIBS Show Promise for Paclitaxel-Coated Balloons in PAD and CAD

Pulmonary artery denervation to treat pulmonary arterial hypertension: a single-center, prospective, first-in-man PADN-1 study

Pulmonary Artery Denervation for Pulmonary Hypertension: PADN-1 Results and Fuure Clinical Studies

Is There Utility in Close Duplex Follow-up After PAD Intervention?

Current Status of Lipid Lowering Therapy in CAD, PAD, and CKD

Per-Lesion Inter-observer Variability and Impact on Syntax Score

4q25 and Prediction of Atrial Fibrillation: How Can This Information Help the Clinician?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content